ID   NCC-DFSP3-C1
AC   CVCL_ZE79
DR   Wikidata; Q98127433
RX   PubMed=32356243;
WW   https://en.cellline.jp/product/ncc-dfsp3-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: ~28 hours (PubMed=32356243).
CC   Sequence variation: Gene fusion; HGNC; 2197; COL1A1 + HGNC; 8800; PDGFB; Name(s)=COL1A1-PDGFB (PubMed=32356243).
CC   Omics: SNP array analysis.
CC   Derived from site: Metastatic; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=32356243
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D21S11: 29,30
ST   D5S818: 10,11
ST   D7S820: 13,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 8
//
RX   PubMed=32356243; DOI=10.1007/s13577-020-00365-3;
RA   Yoshimatsu Y., Noguchi R., Tsuchiya R., Sei A., Nakagawa M.,
RA   Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-DFSP3-C1: a novel
RT   patient-derived dermatofibrosarcoma protuberans cell line.";
RL   Hum. Cell 33:894-903(2020).
//